Paclitaxel trevatide | Interleukin Related interleukin-related.com

Product Name :
Paclitaxel trevatide

Search keywords :
ANG1005

drugId :
null

Target Vo:
Tubulin

Target Vo Short Name :
Tubulin

Moa_Name:
Mitosis inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Angiochem Inc

Active Company_Name :
Angiochem Inc

Active Indication_Name:
Meningeal Carcinomatosis

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glucose Transporter GLUT1 Antibody
B-Raf Antibody
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918): SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) is an unconjugated, approximately 46 kDa, mouse-derived, anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid (YA918) monoclonal antibody. SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) can be used for: WB, ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts